ADAR1 Capital Management reports acquisition of $12,718.7996 in InMed Pharmaceuticals common shares
INM•ADAR1 Capital Management reported purchases of 9,569 InMed Pharmaceuticals common shares, increasing indirect beneficial ownership to 955,493 shares.
1. Share purchases
ADAR1 Capital Management reported purchases of 8,585 shares at $1.33 each and 984 shares at $1.3219 each. Daniel Schneeberger, the firm's manager, was also listed as a reporting owner; both were designated 10% owners.
